Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes

Conditions

Diabetes Mellitus, Type 1

What is the purpose of this trial?

The purpose of this study is to assess how glucagon administered as a puff into the nose (AMG504-1) works in children and adolescents compared with commercially-available glucagon given by injection. In addition, the safety and tolerability of glucagon given as a puff into the nose will be evaluated.


Participation Guidelines

Age:
4 Years - 16 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Jaeb Center for Health Research
Dates:
12/02/2013
Last Updated:
Study HIC#:
1307012428